Decreased Recognition of SUMO-Sensitive Target Genes following Modification of SF-1 (NR5A1)
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
SUMO modification of nuclear receptors, including the constitutively active receptor steroidogenic factor 1 (SF-1; NR5A1), is proposed to repress their transcriptional activity. We examined the functional and structural consequences of SF-1 sumoylation at two conserved lysines (Lys119 and Lys194) that reside adjacent to the DNA-binding domain (DBD) and ligand-binding domain (LBD), respectively. Surprisingly, while previous loss-of-function studies predicted that sumoylation at Lys194 would greatly impact SF-1 function, the conformation and coregulator recruitment of fully sumoylated SF-1 LBD protein was either unchanged or modestly impaired. Sumoylation at Lys194 also modestly reduced Ser203 phosphorylation. In contrast to these findings, sumoylation of the DBD at Lys119 resulted in a marked and selective loss of DNA binding to noncanonical SF-1 targets, such as inhibinalpha; this binding deficit was extended to all sites when the sumoylated human mutant (R92Q) protein, which exhibits lower activity, was used. Consistent with this result, the K119R mutant, compared to wild-type SF-1, was selectively recruited to a "SUMO-sensitive" site in the endogenous inhibinalpha promoter, leading to increased transcription. DNA binding and sumoylation of Lys119 appeared to be mutually exclusive, suggesting that once SF-1 is bound to DNA, sumoylation may be less important in regulating SF-1 activity. We propose that sumoylation of nuclear receptors imposes an active posttranslational mark that dampens recognition of SUMO-sensitive target genes to restrain their expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Luo, X., Ikeda, Y., & Parker, K. L. (1994) · Cell · doi:10.1016/0092-8674(94)90211-9 · Cited by 1,631
Steroidogenic factor 1: a key determinant of endocrine development and function
Parker, K. L., & Schimmer, B. P. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0301 · Cited by 764
SUMO-Specific Protease 1 Is Essential for Stabilization of HIF1α during Hypoxia
Cheng, J., Kang, X., Zhang, S., & Yeh, E. T. H. (2007) · Cell · doi:10.1016/j.cell.2007.08.045 · Cited by 624
Ghisletti, S., Huang, W., Ogawa, S., Pascual, G., Lin, M.-E., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.11.022 · Cited by 561 · cited 1×
“and can also relieve transrepression (16, 19, 33, 43).”
BackgroundPhosphorylation of the Nuclear Receptor SF-1 Modulates Cofactor Recruitment
Hammer, G. D., Krylova, I., Zhang, Y., Darimont, B. D., Simpson, K., Weigel, N. L., & Ingraham, H. A. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80480-3 · Cited by 375
Self-citationAchermann, J. C., Ozisik, G., Ito, M., Orun, U. A., Harmanci, K., Gurakan, B., & Jameson, J. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8376 · Cited by 305 · cited 9×
“Intriguingly, a homozygous missense human mutation is found in the A-box region of SF-1, resulting in an arginine-to-glutamine substitution (R92Q) (1).”
BackgroundInfluentialGummow, B. M., Scheys, J. O., Cancelli, V. R., & Hammer, G. D. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0461 · Cited by 114
Chen, W.-Y., Lee, W.-C., Hsu, N.-C., Huang, F., & Chung, B.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405006200 · Cited by 104 · cited 3×
“Although earlier studies suggested that SUMO-modified SF-1 retains the ability to bind DNA, these studies were unable to separately assess the binding of the sumoylated SF-1 from unmodified SF-1 (8, 31).”
BackgroundBeads-on-a-String, Characterization of Ets-1 Sumoylated within Its Flexible N-terminal Sequence
Macauley, M. S., Errington, W. J., Schärpf, M., Mackereth, C. D., Blaszczak, A. G., Graves, B. J., & McIntosh, L. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510488200 · Cited by 36
Cited by
Guo, S.-W. (2009) · Molecular Human Reproduction · doi:10.1093/molehr/gap064 · Cited by 328
“Xue et al. (2007b) showed that SF-1 promoter has increased methylation in endometrial cells yet in endometriotic cells it is hypomethylated.”
BackgroundInfluentialIto, A., Hong, C., Rong, X., Zhu, X., Tarling, E. J., Hedde, P. N., Gratton, E., Parks, J., & Tontonoz, P. (2015) · eLife · doi:10.7554/elife.08009 · Cited by 281
“Interestingly, the nuclear receptor SF-1 can be modified by SUMO in its hinge region and this modification has been shown to be functionally important for gene repression in vivo (Campbell et al., 2008; Lee et al., 2011).”
BackgroundMinireview: steroidogenic factor 1: its roles in differentiation, development, and disease
Schimmer, B. P., & White, P. C. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0519 · Cited by 268
“Perhaps the posttranslational modifications of SF-1 are influenced by the cyclical and dynamic recruitment of SF-1 into active transcription complexes because, for example, DNAbound SF-1 is refractory to SUMO-ylation at K113 (87).”
Influential
Metadata
- Authors
- Campbell, L. A., Faivre, E. J., Show, M. D., Ingraham, J. G., Flinders, J., Gross, J. D., & Ingraham, H. A.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2008-12-01
- Volume
- 28
- Issue
- 24
- Pages
- 7476-7486
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2116755431
- Cited by
- 59
- References
- 9
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.